Back to Results
First PageMeta Content
Medicine / Bacterial diseases / Proteobacteria / Meningococcal disease / Meningococcal vaccine / Meningitis / Neisseria / Influenza vaccine / Vaccination / Bacteria / Vaccines / Microbiology


NFID CLINICAL UPDATES Addressing the Challenges of Serogroup B Meningococcal Disease Outbreaks on Campuses William Schaffner, MD,* Carol J. Baker, MD,†‡ Lynn Bozof,§ Jeffrey Engel, MD,║
Add to Reading List

Open Document

File Size: 450,01 KB

Share Result on Facebook

City

Rosenstein / Houston / Santa Barbara / Philadelphia / Maples / Basel / Edwards / Jackson / Charlottesville / New York / Atlanta / Nashville / /

Company

Novartis Vaccines and Diagnostics Inc. / Novartis / Genentech / Pfizer Inc. / Cubist / Merck & Co / Inc / Sanofi / Stephens / Merck & Co Inc. / Sigma-Tau Pharmaceuticals Inc. / Novartis Vaccines / MedImmune / Serogroup / Dynavax / Immunization Practices / B Vaccine Currently / Meningococcal Serogroup / Immunization Practices Meningococcal Vaccine Work Group / /

Continent

Europe / /

Country

Switzerland / Canada / Australia / United Kingdom / United States / Greece / /

/

Event

FDA Phase / /

Facility

Children’s Hospital of Philadelphia / Texas Children’s Hospital / University of Pennsylvania School / University of California / Princeton University / UCSB campus / University of Virginia School / †Baylor College of Medicine / Social Norms Institute / /

/

Holiday

Thanksgiving / Halloween / /

IndustryTerm

prevention of meningococcal disease / food / healthcare professionals / treatment of serious infections due to meningococcal disease / prevention of meningococcal B disease / dedicated Web site / printing / /

MedicalCondition

chickenpox / septic shock / B disease / pneumonia / Y. Meningococcal disease / low-grade fever / fever / vomiting / kidney failure / diseases / B invasive meningococcal disease / infection / tonsillitis / rash / infectious disease / unpredictable disease / meningococcal infections / headache / flu / petechial rash / nausea / purpura fulminans / serious infections / meningococcal disease / MS / hearing loss / influenza / invasive meningococcal disease / bacteremia / disease / sometimes fatal infection / meningococcal infection / Infectious Diseases / meningitis / /

MedicalTreatment

vaccination / antibiotic therapy / chemoprophylaxis / foot amputations / immunization / antibiotics / counseling / antibiotic prophylaxis / amputations / vaccinations / /

Organization

University of Pennsylvania School of Medicine / University of California / Santa Barbara / Princeton University / University of Virginia School of Medicine / Drexel University / Baylor College of Medicine / Infectious Diseases / and Vaccine Education Center / FDA / Department of Health / Children’s Hospital of Philadelphia / Accreditation Council for Continuing Medical Education / Department of Health Policy / National Foundation for Infectious Diseases / NFID CME Office / Center for Vaccine Awareness & Research / §National Meningitis Association / Centers for Disease Control and Prevention / Vanderbilt University School of Medicine / Council of State and Territorial Epidemiologists / Division of Infectious Diseases / US Food and Drug Administration / Texas Children’s Hospital / Social Norms Institute / /

Person

Mary Ferris / James C. Turner / Carol J. Baker / Paul A. Offit / Jeffrey Engel / Jessica MacNeil / Peter Johnsen / Lynn Bozof / § Jeffrey / Susan J. Rehm / William Schaffner / Marla Dalton / Amanda Cohn / Wellington Sun / Ellyn Terry / /

/

Position

advisor / representative / speaker / medical director / consultant / director / content reviewer / /

Product

ciprofloxacin / B / B vaccine / Australia.7 This vaccine / US / /

ProvinceOrState

Nebraska / Virginia / Indiana / Louisiana / Connecticut / Mississippi / California / Georgia / Texas / Wisconsin / Maryland / Tennessee / Pennsylvania / /

PublishedMedium

Lippincott Williams & Wilkins / /

Technology

html / /

URL

http /

SocialTag